Carillon Tower Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Carillon Tower Advisers’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$9.13M	Sell	19,600 -700	-3%	-$328K	0.06%	342
2020 Q3	$8.96M	Sell	20,300 -1,500	-7%	-$620K	0.12%	268
2020 Q2	$7.9M	Sell	21,800 -1,400	-6%	-$469K	0.06%	318
2020 Q1	$6.58M	Sell	23,200 -3,800	-14%	-$1.2M	0.06%	317
2019 Q4	$8.77M	Sell	27,000 -1,900	-7%	-$576K	0.06%	345
2019 Q3	$8.42M	Sell	28,900 -1,000	-3%	-$286K	0.06%	347
2019 Q2	$8.78M	Hold	29,900	–	–	0.06%	346
2019 Q1	$8.18M	Buy	29,900 +4,800	+19%	+$1.19M	0.06%	353
2018 Q4	$5.62M	Buy	+25,100	New	+$5.89M	0.05%	350
2018 Q3	–	Sell	-34,700	Closed	-$7.19M	–	472
2018 Q2	$7.19M	Buy	+34,700	New	+$7.37M	0.06%	356

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Carillon Tower Advisers's TMO Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Thermo Fisher Scientific (TMO) stake by 3.4% in Q4 2020, selling an estimated $328K and leaving 19,600 shares worth $9.13M. The position accounts for 0.06% of the portfolio, ranked #342.

Carillon Tower Advisers first reported a position in TMO in Q2 2018 and has held it in 10 quarters since. 2,032 funds tracked by Wall St. Rank hold TMO as of Q4 2020.

Carillon Tower Advisers held 19,600 shares of Thermo Fisher Scientific worth $9.13M as of Q4 2020.
Carillon Tower Advisers sold 700 Thermo Fisher Scientific shares in Q4 2020, an estimated $328K.
Thermo Fisher Scientific made up 0.06% of Carillon Tower Advisers's portfolio in Q4 2020, its #342 holding.
Carillon Tower Advisers first reported a position in Thermo Fisher Scientific in Q2 2018 and has held it in 10 quarters since.
2,032 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.